Journalists can register now for ECCO 14 -- the European Cancer Conference
... ... ECCO is recognised as one of the worlds leading multidisciplinary cancer conferences and provides a unique European forum for presentations of exciting new research from experimental and clinical oncologists, epidemiologists and cance...New ECCO 13 studies probe impact of haematological cancer therapy on future fertility
Paris, France, Thursday 3 November 2005 - Despite the proven positives of chemotherapy and radiotherapy in improving clinical outcomes for cancer sufferers, these survival benefits can come at a cost. In an effort to further assess the long-term impact of cancer treatment, two studies showcased at the 13th European Cancer Conference (ECCO) have examined the effect of chemotherapy and radiotherapy...ECCO 13 - Sunitinib prolongs survival in GIST patients after imatinib mesylate failure
Paris, France, Thursday 3 November 2005 - Updated results from a Phase III trial presented at the 13th European Cancer Conference (ECCO) show that sunitinib (SU11248) prolongs both progression-free and overall survival in patients with progressive metastatic and/or unresectable GIST whose disease has failed to respond to the standard therapy - imatinib mesylate....... This study was a double-blin...Calls for improved screening of colorectal cancer in Europe's aging population at ECCO 13
Paris, France, Tuesday 1 November 2005 - Colorectal cancer is a significant public health problem for which differing treatment regimes hold different benefits in associated efficacy, safety and tolerability, according to study findings showcased at the 13th European Cancer Conference (ECCO)....... Speaking at ECCO 13, leading expert in colorectal cancer epidemiology and prevention, Professor Pet...New ECCO studies highlight promising potential of cancer immunotherapy
Paris, France, Wednesday 2 November 2005 - New research findings showcased at the 13th European Cancer Conference (ECCO) have highlighted the important therapeutic potential of immunotherapy in the treatment of a number of different cancers e.g. for treatment of renal and skin cancers....... Renal cancer is the 6th leading cause of cancer death with a survival rate of 11% for stage-IV disease. Mo...ECCO 13 offers new insights into patients' perceptions of cancer
Paris, France, Wednesday 2 November 2005 - New light has been shed on patients' perception of cancer following the results of studies, presented at the 13th European Cancer Conference (ECCO), which focused on the sufferer's own perspectives. In particular, new insights have been gained into the use of complementary and alternative medicines (CAM) following a diagnosis of cancer. Patient communica...ECCO 13 explores issues in cancer patient management
Paris, France, Wednesday 2 November - New study findings showcased at the 13th European Cancer Conference (ECCO) have shed further light on the manifold factors which must be considered when managing patients with cancer. Studies from around Europe looked at a number of the issues faced by cancer patients and assessed their impact and associated implications. ...... Greek researchers undertook a...New ECCO 13 data emphasise vital importance of cervical cancer detection, treatment and prevention
Paris, France, Wednesday 2 November 2005 - Despite intensive efforts focused on detection and early treatment, in certain populations cervical cancer rates are rising and medical therapy remains inadequate, according to data presented at the 13th European Cancer Conference (ECCO)....... In sub-Saharan Africa, insufficient radiotherapy appears to be hindering the survival prospects for women with...ECCO 13 - Chernobyl legacy sheds light on link between thyroid cancer and radiation exposure
Paris, France, Tuesday 1 November 2005 - Study results presented at the 13th European Cancer Conference (ECCO 13) have provided further valuable insights into certain genetic mutations which occur in childhood thyroid tumours and their link to both radiation exposure and patient age. ...... The unique circumstances of this study were provided for by the legacy of the radioactive accident at Chern...ECCO 13 evidence suggests link between Chlamydia and OAL
Paris, France, Monday 31 October 2005 - Infection with a bacteria from the Chlamydia family may be linked to the development of a type of lymphoma which affects the tissues surrounding the eye, according to results released at the 13th European Cancer Conference (ECCO)....... Several infectious agents have been pinpointed as potential risk factors for lymphoma development. Members of the Chlamydi...ECCO 13 - One voice, one vision needed to overcome cancer in Europe
Monday 31 October, Paris, France Despite improved technologies and treatments following a decade of exciting progress in cancer research, Europe is failing to meet the expectations of patient and healthcare professionals on the standard of cancer care according to the first patient programme held by Federation of European Cancer Societies at ECCO 13. The event, involving patients, healthcare pro...